financetom
OMI
financetom
/
Healthcare
/
OMI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Owens & Minor, Inc.OMI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
533.01M
Revenue (ttm)
10.70B
Net Income (ttm)
-362.69M
Shares Out
77.25M
EPS (ttm)
-4.73
PE Ratio
n/a
Forward PE
3.90
Dividend
n/a
Ex-Dividend Date
n/a
Volume
542,352
Open
7.15
Previous Close
7.00
Day's Range
6.67 - 7.23
52-Week Range
6.07 - 26.05
Beta
1.02
Analysts
Hold
Price Target
16.07 (+132.9%)
Earnings Date
May 2, 2025
Description >

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide.

It operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Its portfolio of medical and surgical supplies includes branded products and its proprietary products.

This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers.

The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment.

This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services.

It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors.

The company was founded in 1882 and is headquartered in Richmond, Virginia.

Latest News >
Merck Says Phase 3 Trial of Keytruda in Triple Negative Breast Cancer Met Overall Survival Endpoint
Merck Says Phase 3 Trial of Keytruda in Triple Negative Breast Cancer Met Overall Survival Endpoint
May 28, 2024
07:34 AM EDT, 05/28/2024 (MT Newswires) -- Merck ( MRK ) said Tuesday that a phase 3 trial evaluating Keytruda in combination with chemotherapy as a treatment for patients with high-risk early-stage triple-negative breast cancer met its overall survival endpoint. The trial evaluated the combination therapy as a pre-operative treatment and as a single agent after surgery, Merck ( MRK...
Energy Capital Partners to acquire Atlantica for $2.56 bln
Energy Capital Partners to acquire Atlantica for $2.56 bln
May 28, 2024
May 28 (Reuters) - Private equity firm Energy Capital Partners will buy Atlantica Sustainable Infrastructure ( AY ) for $2.56 billion in cash, the utility said on Tuesday, in a deal that will give its biggest shareholder funds to lower its debt. Atlantica, which started a strategic review in February last year, will get $22 per share, a near 19%...
Baozun Beats Revenue Estimates with Strong Q1 Growth, Shares Surge
Baozun Beats Revenue Estimates with Strong Q1 Growth, Shares Surge
May 28, 2024
Baozun Inc ( BZUN ) reported a fiscal first-quarter 2024 revenue growth of 4.9% year-on-year to 1.98 billion Chinese yuan ($274.2 million), beating the analyst consensus estimate of $269.6 million. Adjusted loss per ADS was $0.03, compared to the analyst consensus estimate of $0.00. The stock price gained after the results. The increase in total net revenues was mainly due to higher product sales...
--PayPal Planning to Build Ad Business, The Wall Street Journal Reports
--PayPal Planning to Build Ad Business, The Wall Street Journal Reports
May 28, 2024
07:34 AM EDT, 05/28/2024 (MT Newswires) -- Price: 62.42, Change: +0.78, Percent Change: +1.27 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved